Risultati della ricerca - Cleton-Jansen, A-M
- Mostra 1 - 19 risultati su 19
-
1
Pathology of primary malignant bone and cartilage tumours di Rozeman, L. B., Cleton-Jansen, A. M., Hogendoorn, P. C. W.
Pubblicazione 2006testo -
2
-
3
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes. di Moerland, E., Breuning, M. H., Cornelisse, C. J., Cleton-Jansen, A. M.
Pubblicazione 1997testo -
4
-
5
-
6
-
7
-
8
-
9
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type di Vos, C B J, Haar, N T ter, Rosenberg, C, Peterse, J L, Cleton-Jansen, A-M, Cornelisse, C J, Vijver, M J van de
Pubblicazione 1999testo -
10
-
11
-
12
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways di Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Pubblicazione 2009testo -
13
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways di Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Pubblicazione 2009testo -
14
-
15
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3 di Cleton-Jansen, A-M, Moerland, E W, Pronk, J C, van Berkel, C G M, Apostolou, S, Crawford, J, Savoia, A, Auerbach, A D, Mathew, C G, Callen, D F, Cornelisse, C J
Pubblicazione 1999testo -
16
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines di Lombaerts, M, van Wezel, T, Philippo, K, Dierssen, J W F, Zimmerman, R M E, Oosting, J, van Eijk, R, Eilers, P H, van de Water, B, Cornelisse, C J, Cleton-Jansen, A-M
Pubblicazione 2006testo -
17
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery di PosthumaDeBoer, J, Piersma, S R, Pham, T V, van Egmond, P W, Knol, J C, Cleton-Jansen, A M, van Geer, M A, van Beusechem, V W, Kaspers, G J L, van Royen, B J, Jiménez, C R, Helder, M N
Pubblicazione 2013testo -
18
Targeting survivin as a potential new treatment for chondrosarcoma of bone di de Jong, Y, van Oosterwijk, J G, Kruisselbrink, A B, Briaire-de Bruijn, I H, Agrogiannis, G, Baranski, Z, Cleven, A H G, Cleton-Jansen, A-M, van de Water, B, Danen, E H J, Bovée, J V M G
Pubblicazione 2016testo -
19
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables di Launonen, V, Laake, K, Huusko, P, Niederacher, D, Beckmann, M W, Barkardottir, R B, Geirsdottir, E K, Gudmundsson, J, Rio, P, Bignon, Y-J, Seitz, S, Scherneck, S, Bièche, I, Champème, M-H, Birnbaum, D, White, G, Varley, J, Sztán, M, Olah, E, Osorio, A, Benitez, J, Spurr, N, Velikonja, N, Peterlin, B, Borg, Å, Cleton-Jansen, A-M, Devilee, P, Bloigu, R, Lidereau, R, Børresen-Dale, A-L, Winqvist, R
Pubblicazione 1999testo